ConvaTec Group Plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNVVY research report →
Companywww.convatecgroup.com
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes.
- CEO
- Jonathan Peter Mason
- IPO
- 2017
- Employees
- 10,489
- HQ
- Reading, GB
Price Chart
Valuation
- Market Cap
- $5.61B
- P/E
- 32.09
- P/S
- 2.29
- P/B
- 3.70
- EV/EBITDA
- 11.53
- Div Yield
- 2.51%
Profitability
- Gross Margin
- 55.76%
- Op Margin
- 16.51%
- Net Margin
- 7.17%
- ROE
- 10.53%
- ROIC
- 9.62%
Growth & Income
- Revenue
- $2.44B · 6.79%
- Net Income
- $175.41M · -7.92%
- EPS
- $0.35 · -5.91%
- Op Income
- $407.95M
- FCF YoY
- 22.50%
Performance & Tape
- 52W High
- $16.65
- 52W Low
- $10.95
- 50D MA
- $11.92
- 200D MA
- $12.53
- Beta
- 0.78
- Avg Volume
- 43.52K
Get TickerSpark's AI analysis on CNVVY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CNVVY Coverage
We haven't published any research on CNVVY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CNVVY Report →